Immunome, Inc. Profile Avatar - Palmy Investing

Immunome, Inc.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoti…

Biotechnology
US, Exton [HQ]

Resulting Ratios

6 Records · Starting from 2018
Loading...
End of IMNM's Analysis
CIK: 1472012 CUSIP: 45257U108 ISIN: US45257U1088 LEI: - UEI: -
Secondary Listings
IMNM has no secondary listings inside our databases.